ORIGINAL RESEARCH article

Front. Pharmacol., 05 February 2024

Sec. Ethnopharmacology

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1328632

Jiawei Kongsheng Zhenzhong Pill: marker compounds, absorption into the serum (rat), and Q-markers identified by UPLC-Q-TOF-MS/MS

  • 1. College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China

  • 2. Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan, China

  • 3. Shandong Provincial Co-innovation Center of Classic TCM Formula, Jinan, China

Abstract

Background: The Jiawei Kongsheng Zhenzhong pill (JKZP), a Chinese herbal prescription comprised of eight Chinese crude drugs, has been historically employed to treat neurological and psychological disorders. Nevertheless, the ambiguous material basis severely hindered its progress and application.

Purpose: The current study aimed to establish a rapid analytical method for identifying the chemical components of the JKZP aqueous extract and the components absorbed into the rat serum to investigate the quality markers (Q-markers) responsible for the neuroprotective effects of JKZP.

Methods: The qualitative detection of the chemical components, prototype components, and metabolites of the aqueous extracts of JKZP, as well as the serum samples of rats that were administered the drug, was performed using the ultra-performance liquid chromatography- quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS) technology. This analysis combined information from literature reports and database comparisons. Moreover, the study was conducted to anticipate the potential Q-markers for the neuroprotective effects of JKZP based on the “five principles” of Q-marker determination.

Results: A total of 67 compounds and 111 serum components (comprising 33 prototypes and 78 metabolites) were detected and identified. Combining the principles of quality transmission and traceability, compound compatibility environment, component specificity, effectiveness, and measurability, the study predicted that five key compounds, namely, senkyunolide H, danshensu, echinacoside, loganin, and 3,6′-disinapoyl sucrose, may serve as potential pharmacological bases for the neuroprotective effects of JKZP.

Conclusion: To summarize, the UPLC-Q-TOF-MS/MS technique can be employed to rapidly and accurately identify compounds in JKZP. Five active compounds have been predicted to be the Q-markers for the neuroprotective effects of JKZP. This discovery serves as a reference for improving quality, advancing further research and development, and utilizing Chinese herbal prescriptions.

1 Introduction

The Jiawei Kongsheng Zhenzhong pill (JKZP) was derived from the Kongsheng Zhenzhong pill as documented in the ancient medical classic “Thousand Golden Prescriptions.” The original prescription, consisting of Chinemys reevesii (Gray) (tortoise plastron; also named Guijia in Chinese), Os Draconis (Fossilia Ossia Mastodi) (dragon bones; also named Longgu in Chinese), Polygalae tenuifolia Willd (Radix Polygalae; also named Yuanzhi in Chinese), and Acorus tatarinowii Schott (Acorus Tatarinowii; also named Shichangpu in Chinese), manifested effects in tonifying the kidneys, tranquilizing the heart, enhancing wisdom, and soothing the mind. It was also esteemed as a conventional prescription for heightening wisdom and enlightenment. Consequently, its primary objective was to address conditions such as insomnia, amnesia, Alzheimer's disease, vascular cognitive impairment, depression, pediatric hyperactivity disorder, and similar ailments clinically (Rui and Yue, 2012; Hou et al., 2021; Chen et al., 2022). In accordance with traditional Chinese medicine (TCM) theory and clinical experience, Salvia miltiorrhiza Bunge (Salviae Miltiorrhizae; also named Danshen in Chinese), Ligusticum sinense ‘Chuanxiong’ (Chuanxiong Rhizoma; also named Chuanxiong in Chinese), Cornus officinalis Sieb. et Zucc. (Corni Fructus; also named Shanzhuyu in Chinese), and Cistanche deserticola Ma (Cistanches Herba; also named Roucongrou in Chinese) were incorporated into the original prescription to reinforce the effects of kidney and marrow tonification, blood circulation activation, blood stasis removal, and depression relief. Its principal application targeted symptoms associated with renal essence deficiency and blood stasis. What is more, it has demonstrated notable therapeutic effectiveness in addressing vascular cognitive impairment and post-stroke depression, exhibiting a commendable neuroprotective effect (Yu et al., 2013; Wu et al., 2015; Pang et al., 2016; Song, 2022; Yu et al., 2016; Zhou, 2022). However, the components of JKZP are relatively multifarious, and the precise pharmacological basis for its neuroprotective effect requires further elucidation. The compositions and proportions of JKZP are shown in Table 1.

TABLE 1

English nameBotanical nameChinese namePart usedProportion
Tortoise plastronChinemys reevesii (Gray)GuijiaShell6
Dragon bonesOs Draconis (Fossilia Ossia Mastodi)LongguBone fossils of big mammals6
Radix PolygalaePolygalae tenuifolia WilldYuanzhiRoot3
Acorus TatarinowiiAcorus tatarinowii SchottShichangpuRoot3
Salviae MiltiorrhizaeSalvia miltiorrhiza BungeDanshenRoot and rhizome5
Chuanxiong RhizomaLigusticum sinense ‘Chuanxiong'ChuanxiongRhizome4
Corni FructusCornus officinalis Sieb. et ZuccShanzhuyuSarcocarp5
Cistanches HerbaCistanche deserticola MaRoucongrouSucculent stem4

Composition of Jiawei Kongsheng Zhenzhong pill (JKZP).

The plant name has been checked and confirmed with the WFO Plant List and Plants of the World Online | Kew Science.

Over the past few decades, an increasing number of studies have reported the components in the aqueous extract and the serum of the single plant drug in JKZP (Li et al., 2008; Yun et al., 2018; Hou, 2019; Qu et al., 2020; Yang et al., 2020; Zhao et al., 2020), which are aligned with prior research, and certain components that exhibit noteworthy neuroprotective activities (Feng et al., 2017; Wang et al., 2020a; Tang X. et al., 2022; Lu et al., 2022). Nevertheless, research reports regarding the analysis and identification of compounds in the whole prescription of JKZP require further elaboration. Quality markers (Q-markers) are compounds intricately linked to the pharmacological properties of herbs, particularly their effectiveness and measurability. They served for quality control in single herbs and Chinese herbal prescriptions, revealing potential pharmacological substance foundations, thus facilitating further research, development, and utilization (Jiang et al., 2023). The widely utilized technology for the qualitative detection of compounds in TCM is ultra-performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS). This technology is distinguished by its robust separation capability, high sensitivity, and convenience. The components in the sample are ionized, resulting in ions with a certain charge and different mass numbers. Different ions have different motion behaviors in the electromagnetic field. The mass analyzer is used to separate ions according to the different mass-to-charge ratios (m/z), obtaining the mass spectra in the order of the mass-to-charge ratios and then comparing these with the database, which can be used for the identification of the properties of the compounds (Chen et al., 2023a).

Hence, this study conducted preliminary qualitative analyses and identifications of the aqueous extract of JKZP and JKZP-containing serum of rats using the UPLC-Q-TOF-MS/MS technique. Concurrently, leveraging the neuroprotective effect of JKZP, potential Q-markers were forecasted following the ‘five principles’ of Q-marker determination. This study sought to contribute insights and foundations for conducting fundamental research on the pharmacological substances of Chinese herbal prescriptions and improving the criteria for quality control.

2 Materials and methods

2.1 Apparatus

Waters H-Class UPLC (Waters, United States), AB Sciex Triple TOF® 4600 high-resolution mass spectrum (SCIEX, United States), KQ-300 BD ultrasonic cleaning instrument (Kunshan Ultrasonic Instrument, China), Sigma 3K15 high-speed centrifuge (Sigma, United States), LNG-T98 centrifugal concentration dryer (Taicang Huamei, China), and R583S small animal anesthesia machine (RWD, China) were used for this study.

2.2 Reagents and materials

The reagents and materials used for the study involved Chinese medicinal decoction pieces of JKZP (tortoise plastron, lot: 19081001; dragon bones, lot: 20200201; Radix Polygalae, lot: 20113001; Acorus Tatarinowii, lot: 20103001; Salviae Miltiorrhizae, lot: 20121401; Chuanxiong Rhizoma, lot: 20092103; Corni Fructus, lot: 20040801; Cistanches Herba, lot: 21021904), which were purchased from Shandong Bokang TCM Decoction Pieces Co. Ltd and identified as genuine, acetonitrile (MS pure, I1133829105, Merck company), methanol (MS pure, I1139035113, Merck company), formic acid (MS pure, Y6170039, CNW company), purified water (20221110C, Guangzhou Watsons Food and Beverage Co., Ltd.), and isoflurane (R510-22-10, Shenzhen Ruiwode Life Technology Co., Ltd.).

2.3 Preparation of the JKZP aqueous extract solution

To ensure the consistency of JKZP, the quality of each herb was evaluated before use, and the extraction of the decoction followed the standardized procedures specified in the “Pharmacopoeia of the People's Republic of China.” Chuanxiong Rhizoma (120 g) and Acorus Tatarinowii (90 g) were broken and soaked in a distillation flask for 30 min, and then volatile oil was extracted by distillation for 6 h. The volatile oil was taken out, and the filtrate and dregs were stored temporarily. After soaking for 60 min, the tortoise plastron (180 g) and dragon bones (180 g) were broken into pieces and decocted for 30 min and then added to the other medicines (Radix Polygalae, 90 g; Salviae Miltiorrhizae, 150 g; Corni Fructus, 150 g; and Cistanches Herba, 120 g) and dregs of Chuanxiong Rhizoma and Acorus Tatarinowii, and the entire mixture was then sequentially decocted for 45 min. The second decoction was made, and the filtrate was combined and filtered. The filtrate was concentrated by spinning in a water bath at 65°C, the volatile oil was combined, and the concentration of the drug aqueous extract solution was adjusted to 3.6 g mL−1 and stored at 4°C.

2.4 Animals, drug administration, and serum samples' pretreatment

Healthy male SD rats of SPF grade with a body weight of 250 ± 10 g were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd., under animal production license no. SCXK (Beijing) 2021-0011. They were raised in an environment with a temperature of 20–26°C, relative humidity of 55 ± 10%, and light/darkness cycle of 12 h each, with ad libitum access to food and water. The animal handling during this experiment adhered to China's “Regulations on the Management of Laboratory Animals” and the relevant regulations of the Ethics Committee of the Laboratory Animal Center of Shandong University of Traditional Chinese Medicine. The study received ethical approval, with the number SDUTCM20221021004.

A total of 20 rats were randomly allocated into a JKZP-containing serum group and a blank serum group, with 10 rats in each group. In the JKZP-containing serum group, rats received 56.7 g kg−1 d−1 of JKZP through gavage (calculated based on an adult body weight of 60 kg, and five times the equivalent clinical dose) for five consecutive days. The blank serum group received an equal volume of saline.

Within 1 h post final intragastric administration, continuous anesthesia was induced by inhaling 3% isoflurane. Blood was drawn from the abdominal aorta and left at room temperature for 2 h. Subsequently, serum separation was performed by centrifugation at 3000 rpm min−1 for 15 min. The complement was inactivated using a constant temperature water bath set at 56°C for 30 min. The serum from the same group was pooled to minimize individual variations, sub-packaged, and stored at −80°C for subsequent use.

2.5 Preparation of the sample solution

For the JKZP aqueous extract sample, 1 mL of the JKZP aqueous extract was placed in a centrifuge tube, and 2 mL of 20% methanol was added, then the supernatant was collected after centrifugation at 12,000 rpm min−1 for 15 min. For the serum sample, 2 mL of the rat blank serum and 2 mL of JKZP-containing serum were taken separately. Thrice the volume of methanol (mass spectrometry grade) was added to the precipitate proteins. The mixture was thoroughly mixed and stored at 4°C for 20 min, followed by centrifugation to obtain the supernatant. The supernatant was concentrated, dried by centrifugation, and stored at −80°C. The residue was dissolved in 200 μL of 50% methanol before analysis, thoroughly mixed, and then centrifuged to obtain the supernatant.

2.6 Chromatographic and mass spectrometry conditions

The chromatography analysis was performed using Waters® CORTECS® UPLC® T3 (1.6 µm, 2.1 mm × 100 mm) at 30°C. The mobile phase consisted of acetonitrile (A) and 0.1% formic acid in water (B). The gradient elution with the following program was carried out as follows: 0–3 min, 0% A; 3–7 min, 0%–5% A; 7–30 min, 5%–13% A; 30–55 min, 13%–25% A; 55–67 min, 25%–40% A; 67–72 min, 40%–95% A; 72–75 min, 95% A; 75–75.1 min, 95%–0% A; 75.1–78 min, 0% A. The flow rate was set at 0.3 mL min−1, the detection wavelength was 190–400 nm, and the injection volume was 2–5 μL. The MS detection was applied in an ESI-negative/positive ion mode.

2.7 Data analysis

Data analysis was conducted using the PeakView 1.2 software. MS data were preferentially matched with the Natural Products HR-MS/MS Spectral Library 1.0 database for identification by comparison with the controls. Compounds were initially screened based on the data of each peak and subsequently confirmed using the primary and secondary information of each peak. Subsequently, considering the preliminary analysis of the identified components using the UPLC-Q-TOF-MS/MS technique, potential Q-markers for the neuroprotective effect of JKZP were predicted following the five principles of Q-marker determination.

3 Results

3.1 Acquisition and identification of the UPLC-Q-TOF-MS/MS chromatogram of the JKZP aqueous extract

Under the aforementioned chromatographic and MS conditions, total ion flow diagrams of the JKZP aqueous extract were, respectively, collected in positive and negative ion modes. As illustrated in Figure 1A, B, the initial observation of the images revealed that the total ion flow map was clear, enabling data analysis. The results exhibited a high degree of reliability. More narrowly, the peak of gallic acid merged in 3.44 min, labeled as No. 4 in Figure 1A, while the peak of danshensu appeared in 7.05 min, described as No. 9 also in Figure 1A.

FIGURE 1

Utilizing the multistage MS information of the samples, coupled with the natural product high-resolution MS database and relevant literature, the ion peaks in the total ion flow diagram of the JKZP samples were identified. As depicted in Table 2, a total of 12 classes and 67 compounds were identified in the whole ion flow diagram of JKZP samples. These included 18 phenolic acids, 13 iridoid glycosides, 10 oligosaccharide esters, four each of amino acids, phenylethanoid glycosides, phthalides, and diterpene quinones, three each of xanthones and nucleosides, two phenylpropanoids, and one each of organic acid and cyclic peptide.

TABLE 2

No.Time (min)Adductionm/z Actual valueMolecular formulaMolecular weightComponentMS/MS dataClassificationSource
12.10[M + H]+132.1014C6H13NO2131.09L-Leucine86.0946; 69.0677; 56.0481Amino acidsGuijia
22.35[M + H]+182.0808C9H11NO3181.07L-Tyrosine136.0765; 119.0494; 107.0490; 91.0542Amino acidsGuijia
32.50[M − H]243.0636C9H12N2O6244.07Uridine243.0633; 200.0583; 152.0368; 110.0257; 82.0299Nucleosides
43.44[M − H]169.0147C7H6O5170.02Gallic acid169.0145; 125.0248; 97.0293; 79.0189Phenolic acidsShanzhuyu
54.73[M + H]+268.1041C10H13N5O4267.10Adenosine268.1030; 136.0611; 119.0346Nucleosides
65.23[M + H]+166.0851C9H11NO2165.08Phenylalanine120.0803; 103.0538; 91.0532; 77.0378Amino acidsGuijia
75.56[M − H]282.0840C10H13N5O5283.09Guanosine282.0872; 150.0428; 133.0158Nucleosides
86.47[M − H]361.0780C14H18O11362.087-O-Galloyl-D-sedoheptulose271.0468; 211.0257; 169.0149; 124.0171Phenolic acidsShanzhuyu
97.05[M − H]197.0458C9H10O5198.05Danshensu179.0351; 135.0451; 123.0452; 72.9931Phenolic acidsDanshen
109.22[M − H]137.0252C7H6O3138.03Protocatechuic aldehyde137.0250; 136.0171; 108.0221; 92.0269Phenolic acidsDanshen
119.36[M + H]+205.0968C11H12N2O2204.09L-Tryptophan188.0696; 170.0583; 146.0592; 118.0644Amino acids
1210.16[M − H]353.0886C16H18O9354.10Neochlorogenic acid353.0881; 191.0565; 179.0356; 135.0455Phenolic acidsChuanxiong
1311.29[M + FA − H]391.1241C15H22O9346.13Aucubin391.1278; 345.1187; 183.0653; 165.0551; 161.0456; 153.0556Iridoid glycosidesShanzhuyu, Roucongrong
1411.93[M − H]375.1290C16H24O10376.14Loganic acid375.1306; 213.0774; 169.0879; 151.0768Iridoid glycosidesShanzhuyu
1512.23[M − H]461.1296C19H26O13462.14Sibiricose A3461.1310; 299.0780; 281.0670; 239.0558; 179.0352; 137.0242Oligosaccharide estersYuanzhi
1612.39[M-H]-567.1950C23H36O16568.20Cornusdiglycoside G567.1402; 405.1398; 285.0977; 243.0865Iridoid glycosidesShanzhuyu
1712.76[M + FA − H]613.2013C23H36O16568.20Cornusdiglycoside H405.1417; 243.0883; 179.0568Iridoid glycosidesShanzhuyu
1812.98[M + FA − H]451.1446C17H26O11406.157α-Morroniside405.1428; 243.0883; 179.0568; 155.0345; 141.0559Iridoid glycosidesShanzhuyu
1913.39[M − H]311.0408C13H12O9312.05Caftaric acid311.0412; 179.0359; 149.0098; 135.0457Phenolic acidsDanshen
2013.96[M + FA − H]451.1466C17H26O11406.15Morroniside451.1487; 405.1418; 243.0883; 179.0568; 155.0360; 141.0564Iridoid glycosidesShanzhuyu
2114.32[M − H]353.0868C16H18O9354.10Chlorogenic acid353.0845; 191.0555; 171.0298; 161.0244Phenolic acidsChuanxiong
2215.45[M − H]389.1081C16H22O11390.12Secoxyloganic acid389.1080; 345.1184; 209.0436; 165.0548Iridoid glycosidesShanzhuyu
2315.72[M − H]353.0881C16H18O9354.10Cryptochlorogenic acid353.0920; 191.0568; 179.0352; 173.0462; 135.0456Phenolic acidsChuanxiong
2415.98[M + FA − H]475.1490C19H26O11430.15Polygalatenoside A475.0942; 429.1415; 307.1024; 255.1052; 121.0298Oligosaccharide estersYuanzhi
2516.23[M − H]517.1554C22H30O14518.16Sibiricose A5517.1572; 337.0921; 193.0504; 175.0398; 160.0162Oligosaccharide estersYuanzhi
2618.17[M − H]547.1685C23H32O15548.17Sibiricose A1547.1651; 341.1066; 223.0605; 205.0499; 190.0261Oligosaccharide estersYuanzhi
2718.74[M + FA − H]403.1244C16H22O9358.13Sweroside403.1255; 357.1185; 195.0667; 125.0249Iridoid glycosidesShanzhuyu
2818.94[M + FA − H]433.1372C17H24O10388.14Cornin433.1362; 387.1318; 255.0771; 123.0451Iridoid glycosidesShanzhuyu
2920.51[M + FA − H]435.1526C17H26O10390.15Loganin435.1509; 227.091; 127.0398; 101.0243Iridoid glycosidesShanzhuyu
3022.11[M − H]515.1219C25H24O12516.13Isochlorogenic acid A515.1213; 353.0885; 335.0774; 191.0568; 179.0355; 135.0454Phenolic acidsChuanxiong
3123.17[M − H]193.0514C10H10O4194.06Ferulic acid178.0274; 134.0377; 133.0296Phenolic acidsChuanxiong, Shichangpu
3224.95[M − H]505.1595C21H30O14506.16Logmalicid A505.1585; 487.1456; 389.1452; 227.0925; 127.0401Iridoid glycosidesShanzhuyu
3326.68[M − H]505.1571C21H30O14506.16Logmalicid B505.1575; 487.1459; 227.0926; 127.0393Iridoid glycosidesShanzhuyu
3427.40[M − H]537.1282C24H26O14538.13Sibiricaxanthone A537.1237; 417.0809; 405.0818; 387.0702; 315.0493; 285.0392; 267.0285XanthonesYuanzhi
3528.07[M + FA − H]607.1875C24H34O15562.19Glomeratose A607.1894; 561.1838; 323.0973; 237.0769; 193.0870Oligosaccharide estersYuanzhi
3630.25[M − H]785.2530C35H46O20786.26Echinacoside785.2515; 623.2213; 461.1679; 161.0251Phenylethanoid glycosidesRoucongrong
3731.28[M − H]567.1409C25H28O15568.14Polygalaxanthone III567.1409; 359.1523; 345.0630; 329.1409XanthonesYuanzhi
3832.17[M − H2O + H]+207.1021C12H16O4224.10Senkyunolide I207.1050; 189.0922; 161.0962; 133.0652; 91.0534PhthalidesChuanxiong
3932.59[M − H]567.1383C25H28O15568.14Polygalaxanthone XI567.1402; 345.0627; 315.0513; 272.0317XanthonesYuanzhi
4032.96[M − H]187.0981C9H16O4188.10Azelaic acid187.0990; 125.0980; 97.0665Organic acidsYuanzhi
4135.01[M − H]799.2696C36H48O20800.27Cistanoside A799.2669; 623.2213; 605.2162; 477.1456; 175.0396Phenylethanoid glycosidesRoucongrong
4235.30[M − H2O + H]+207.1020C12H16O4224.10Senkyunolide H207.1023; 189.0909; 161.0968; 133.0636; 91.0531PhthalidesChuanxiong
4336.09[M − H]537.1048C27H22O12538.11Salvianolic acid H339.0518; 295.0618; 185.0246Phenolic acidsDanshen
4436.36[M − H]623.1979C29H36O15624.21Acteoside623.2013; 461.1676; 161.0245phenylethanoid glycosidesRoucongrong
4537.83[M − H]417.0819C20H18O10418.09Salvianolic acid D417.0800; 197.0449; 175.0396; 157.0284Phenolic acidsDanshen
4638.50[M − H]623.2010C29H36O15624.21Isoacteoside623.2016; 461.1695; 161.0253Phenylethanoid glycosidesRoucongrong
4739.46[M − H]541.1575C24H30O14542.16Cornuside541.1570; 169.0145; 125.0246Iridoid glycosidesShanzhuyu
4839.97[M − H]359.0787C18H16O8360.08Rosmarinic acid197.0457; 179.0351; 161.0246; 133.0297Phenolic acidsDanshen
4941.15[M − H]753.2277C34H42O19754.233,6′-Disinapoyl sucrose753.2296; 547.1709; 519.0969; 205.0521; 190.0299Oligosaccharide estersYuanzhi
5041.31[M − H]717.1509C36H30O16718.15Salvianolic acid E717.1437; 519.0917; 339.0501; 321.0390Phenolic acidsDanshen
5142.95[M − H]537.1078C27H22O12538.11Lithospermic acid493.1141; 295.0617; 203.0357; 185.0251Phenolic acidsDanshen
5243.81[M + H]+679.5136C36H66N6O6678.50Cyclohexaleucyl679.5142; 661.5020; 336.2274; 209.1656Cyclic peptides
5343.93[M − H]681.2049C31H38O17682.21Tenuifoliside A681.2066; 443.1200; 281.0675; 179.0359; 137.0249Oligosaccharide estersYuanzhi
5445.99[M − H]717.1504C36H30O16718.15Salvianolic acid B717.1506; 519.0958; 339.0527; 321.0414Phenolic acidsDanshen
5549.98[M − H]493.1167C26H22O10494.12Salvianolic acid A493.1180; 295.0626; 185.0253Phenolic acidsDanshen
5650.25[M − H]717.1480C36H30O16718.15Salvianolic acid Y717.1532; 519.0972; 339.0518; 321.0407Phenolic acidsDanshen
5752.55[M − 2H]2−747.2313C67H84O381496.46Tenuifoliose L1203.3663; 747.2210; 674.1978; 145.0300Oligosaccharide estersYuanzhi
5852.65[M + FA − H]711.2196C31H38O16666.223-O-[(E)-3,4,5-Trimethoxycinnamoyl]-β-D-fructofuranosyl-(2→1)-(6-O-benzoyl)-α-D-glucopyranoside665.2203; 543.1774; 427.1259; 237.0777Oligosaccharide estersYuanzhi
5959.69[M − H]1379.4160C62H76O351380.42Tenuifoliose AOligosaccharide estersYuanzhi
6063.29[M + H]+209.1178C12H16O3208.11Cis-β-asarone209.1154; 194.0934; 179.0698; 151.0748; 103.0533PhenylpropanoidsShichangpu
6163.69[M + H]+179.1069C11H14O2178.10Methyl eugenol164.0834; 151.0757; 149.0586; 121.0636; 91.0532PhenylpropanoidsShichangpu
6264.03[M + H]+193.1232C12H16O2192.12Senkyunolide A175.1095; 147.1153; 137.0583; 91.0538PhthalidesChuanxiong
6369.38[M + H]+191.1070C12H14O2190.10Ligustilide191.1060; 173.0955; 115.0532; 91.0532PhthalidesChuanxiong
6469.87[M + H]+315.1610C19H22O4314.15Neocryptotanshinone297.1497; 253.1605; 137.0918; 223.1129; 211.1124Diterpene quinonesDanshen
6571.50[M + H]+297.1496C19H20O3296.14Cryptotanshinone297.1494; 279.1389; 267.1006; 251.1433Diterpene quinonesDanshen
6671.58[M + H]+277.0863C18H12O3276.08Tanshinone Ⅰ277.0880; 249.0931; 202.0787; 178.0785Diterpene quinonesDanshen
6772.56[M + H]+295.1346C19H18O3294.13Tanshinone ⅡA295.1322; 277.1221; 249.1272; 219.0802Diterpene quinonesDanshen

Main component identification results of the JKZP aqueous extract.

3.2 Acquisition and identification of UPLC-Q-TOF-MS/MS chromatograms of the serum samples

Total ion flow diagrams of the JKZP-containing serum and blank serum samples were individually collected in positive and negative ion modes (as displayed in Supplementary Figure S1A, B). According to the multistage MS information of the samples, retention time, cleavage pattern, characterization results of the components of the original prescription, and relevant literature, a comparative analysis between JKZP-containing serum and rat blank serum samples was conducted. A total of 111 components were identified from the JKZP-containing serum, which covered 33 prototypical components and 78 metabolites. Specifically speaking, as indicated in Table 3, these mainly included 11 iridoid glycosides (all from Corni Fructus), nine phenolic acids (seven from Salviae Miltiorrhizae, one from Corni Fructus, and one from Chuanxiong Rhizoma), six oligosaccharide esters (all from Radix Polygalae), three xanthones (all from Radix Polygalae), two phenylethanoid glycosides (all from Cistanches Herba), one phthalide (from Chuanxiong Rhizoma), and one diterpene quinone (from Salviae Miltiorrhizae). Additionally, as listed in Supplementary Table S1, 78 metabolites were authenticated in the JKZP-containing serum. These metabolites were all derived from 19 compounds and, then through various metabolic pathways, such as sulfation, methylation, deglycosylation, hydroxylation, dehydroxylation, and glucuronidation, were derivatized into the 78 metabolites. The prototypical components of the JKZP-containing serum are shown in Table 3.

TABLE 3

No.Time (min)Adductionm/z Actual valueMolecular formulaMolecular weightComponentMS/MS dataClassificationSource
P16.68[M − H]361.078C14H18O11362.087-O-Galloyl-D-sedoheptulose361.1149; 271.0470; 211.0246; 168.0063Phenolic acidsShanzhuyu
P27.05[M − H]197.0456C9H10O5198.05Danshensu135.0466; 123.0462; 72.940Phenolic acidsDanshen
P311.68[M − H]345.1185C15H22O9346.13Aucubin345.1209; 299.1169; 89.0260Iridoid glycosidesShanzhuyu, Roucongrong
P412.07[M − H]375.1316C16H24O10376.14Loganic acid375.1293; 179.0533; 169.0871Iridoid glycosidesShanzhuyu
P512.50[M − H]461.1314C19H26O13462.14Sibiricose A3461.1330; 239.0604; 137.0244Oligosaccharide estersYuanzhi
P613.04[M − H]-567.1968C23H36O16568.20Cornusdiglycoside HIridoid glycosidesShanzhuyu
P713.08[M + FA − H]451.1434C17H26O11406.157α-Morroniside405.1428; 243.0869Iridoid glycosidesShanzhuyu
P814.24[M + FA − H]451.1458C17H26O11406.15Morroniside451.1475; 405.1447; 243.0890; 141.0566Iridoid glycosidesShanzhuyu
P916.31[M + FA − H]475.1462C19H26O11430.15Polygalatenoside A429.1594; 307.1010; 121.0298Oligosaccharide estersYuanzhi
P1016.54[M − H]517.1564C22H30O14518.16Sibiricose A5517.1464; 193.0551; 175.0399Oligosaccharide estersYuanzhi
P1118.50[M − H]547.1705C23H32O15548.17Sibiricose A1547.1710; 341.1109; 205.0513Oligosaccharide estersYuanzhi
P1219.06[M + FA − H]403.1266C16H22O9358.13Sweroside345.1518; 195.0650; 125.0247Iridoid glycosidesShanzhuyu
P1319.26[M + FA − H]433.1371C17H24O10388.14Cornin433.1481; 225.0759Iridoid glycosidesShanzhuyu
P1420.89[M + FA − H]435.1524C17H26O10390.15Loganin435.1544; 227.0924; 127.0393Iridoid glycosidesShanzhuyu
P1522.25[M − H]515.1164C25H24O12516.13Isochlorogenic acid A515.1213; 353.0885; 335.0774; 191.0568; 179.0355; 135.0454Phenolic acidsChuanxiong
P1625.27[M − H]505.1574C21H30O14506.16Logmalicid A505.1580; 389.1460; 227.0922Iridoid glycosidesShanzhuyu
P1727.00[M − H]505.1561C21H30O14506.16Logmalicid B505.1627; 227.0898Iridoid glycosidesShanzhuyu
P1827.75[M − H]537.1268C24H26O14538.13Sibiricaxanthone A537.1260; 387.0740; 315.0503; 285.0402; 267.0305XanthoneYuanzhi
P1928.39[M + FA − H]607.1868C24H34O15562.19Glomeratose A607.2120; 561.1859; 323.0976; 237.0776Oligosaccharide estersYuanzhi
P2030.80[M − H]785.2549C35H46O20786.26Echinacoside785.2515; 623.2213; 461.1679; 161.0251Phenylethanoid glycosidesRoucongrong
P2131.60[M − H]567.1344C25H28O15568.14Polygalaxanthone III567.1385; 435.0955; 315.0490; 297.0396; 272.0289XanthoneYuanzhi
P2232.88[M − H]567.1383C25H28O15568.14Polygalaxanthone XI567.1316; 345.0563; 315.0543; 272.0318XanthoneYuanzhi
P2335.01[M − H]799.2702C36H48O20800.27Cistanoside APhenylethanoid glycosidesRoucongrong
P3235.61[M − H2O + H]+207.1024C12H16O4224.10Senkyunolide H207.0978; 161.0957; 133.0659; 91.0506PhthalidesChuanxiong
P2438.20[M − H]417.0819C20H18O10418.09Salvianolic acid D417.0830; 373.0926; 197.0454; 175.0403; 157.0303Phenolic acidsDanshen
P2539.75[M − H]541.1575C24H30O14542.16Cornuside541.1570; 169.0145Iridoid glycosidesShanzhuyu
P2640.40[M − H]359.0788C18H16O8360.08Rosmarinic acid197.0453; 179.0348; 161.0247; 133.0301Phenolic acidsDanshen
P2741.43[M − H]753.2277C34H42O19754.233,6’-Disinapoyl sucrose753.2296; 547.1709; 519.0969; 205.0521; 190.0299Oligosaccharide estersYuanzhi
P2843.40[M − H]537.1072C27H22O12538.11Lithospermic acid493.1188; 313.072; 295.0633; 185.0254Phenolic acidsDanshen
P2946.80[M − H]717.1515C36H30O16718.15Salvianolic acid B717.1569; 519.0987; 339.0540; 321.0407Phenolic acidsDanshen
P3050.44[M − H]493.1173C26H22O10494.12Salvianolic acid A493.1220; 313.0715; 285.0621; 185.0258Phenolic acidsDanshen
P3150.73[M − H]717.1491C36H30O16718.15Salvianolic acid Y717.1578; 519.0947; 321.0406; 295.0653Phenolic acidsDanshen
P3369.88[M + H]+315.1641C19H22O4314.15Neocryptotanshinone253.1620; 237.0932; 223.1130; 181.1025; 165.0701Diterpene quinonesDanshen

Identification of prototypical components in JKZP-containing serum samples.

In the present study, all absorption into the serum corresponded to the identified components of the JKZP aqueous extract. Out of all the components, four metabolites, which were found to remain after the intersection of the metabolites with the components in the JKZP-containing serum and JKZP aqueous extract samples, could also be traced back to the components in the aqueous extract of JKZP. Specifically, pyrogallic acid was derived from gallic acid, hydroxytyrosol was derived from echinacoside, and dihydroferulic acid and caffeic acid were both derived from ferulic acid (as exhibited in Figure 2). In this study, three amino acids (L-leucine, L-tyrosine, and phenylalanine) from the tortoise plastron were identified in both the JKZP aqueous extract and serum, nevertheless, considering that the blood of a normal creature contains a variety of amino acids, such as the three aforementioned amino acids (Fernstrom et al., 1987; Wang et al., 2020b). Then, the rat blank serum was considered as the negative control to eliminate the impact of endogenously occurring substances in rats on the analysis and identification of the JKZP-containing serum. This allowed for the accurate analysis and identification of absorption into the serum of JKZP to the greatest extent possible. The intersection of the components of each sample is revealed in Figure 2.

FIGURE 2

4 The current status of clinical and experimental studies on JKZP

The investigations proposed that JKZP exhibited neuroprotective properties. In the study by Xu (2006), 51 patients were diagnosed with vascular dementia (VD), with 30 patients were assigned to the JKZP treatment group and 21 to the Western medicine control group. The findings revealed that the JKZP therapy group achieved a total effective rate of 76.67%, resulting in considerable enhancements in the patient's MMSE score, primary clinical symptoms, and whole blood viscosity and erythrocyte aggregation patterns. Simultaneously, JKZP also improved the cognitive impairment and self-care skills of dementia patients, demonstrating definite clinical effectiveness. JKZP could also effectively perfect the sleep quality and Chinese medical symptoms of insomnia patients with heart and kidney deficiency type, which had high effectiveness and safety (Chen et al., 2023b). Regarding the molecular mechanism, it has been verified that JKZP possessed advantageous therapeutic effects in rats suffering from focal cerebral ischemia, vascular cognitive impairment, and post-stroke depression. This encompassed safeguarding neurons against programmed cell death, stimulating the growth of cerebral angiogenesis and augmenting the reorganization of synaptic remodeling, resulting in notable enhancements in neurological impairments, cognitive impairment, and depressive behavior (Yu et al., 2013; Wu et al., 2015; Pang et al., 2016; Yu et al., 2016; Song, 2022; Zhou, 2022). However, additional investigation is necessary to elucidate the detailed pharmacological material basis for its neuroprotective impact.

5 Q-marker prediction analysis of neuroprotective effects exerted by JKZP

Changxiao Liu, the Chinese Academy of Engineering, proposed the innovative concept of the Chinese medicine Q-marker. This concept integrated the biological attributes, manufacturing process, and prescription theory of TCM. “Quality transmission and traceability,” “compound compatibility environment,” “component specificity,” “component effectiveness,” and “component measurability” comprised the five most crucial aspects of Q-markers. These aspects effectively facilitated quality control and contributed to enhance the quality of TCM prescriptions (Liu et al., 2016). Using the UPLC-Q-TOF-MS/MS technology and “five principles” of Q-marker determination, the potential Q-markers of JKZP with neuroprotective effects were predicted. This prediction aimed to offer guidance for enhancing the overall quality control and fostering more in-depth applied research and transformative achievements for JKZP. The research strategy is demonstrated in Figure 3.

FIGURE 3

5.1 Q-marker prediction based on quality transmission and traceability

A comprehensive total of 67 compounds, spanning 12 categories, which includes phenolic acids, iridoid glycosides, and oligosaccharide esters, were identified from the aqueous extract of the JKZP using the UPLC-Q-TOF-MS/MS technology. With the exclusion of nucleosides and cyclic peptides, specific attributions were identified for each compound. Among them, Salviae Miltiorrhizae contributed 15 components (comprising phenolic acids and diterpene quinones); Chuanxiong Rhizoma provided nine components (primarily phenolic acids and phthalides); Acorus Tatarinowii furnished three components (phenylpropanoids and phenolic acids); Radix Polygalae yielded 14 components (mainly oligosaccharide esters and phenylpropanoids); Corni Fructus contributed 15 components (phenolic acids and iridoid glycosides); Cistanches Herba added five components (iridoid glycosides and phenylethanoid glycosides); and tortoise plastron supplied three amino acids. The study failed to identify the pertinent components of the dragon bones. According to the report, the main constituents of the dragon bones were inorganic substances, such as calcium carbonate and calcium phosphate, as well as metal elements like iron, potassium, and sodium. Consequently, the relevant components were absent from this study (Chen et al., 2023c).

In the JKZP-containing serum, a comprehensive analysis found a total of 111 blood-entry components, which comprised 33 prototypical components and 78 metabolites (as described in Table 3; Supplementary Table S1). The analysis revealed that the absorption into the serum was derived from a total of 39 original components. Specifically, Chuanxiong Rhizoma exhibited a dominance of phenolic acids and phthalides, Salviae Miltiorrhizae showcased phenolic acids and diterpene quinones, Cistanches Herba featured phenylethanoid glycosides, Corni Fructus presented iridoid glycosides, and Radix Polygalae manifested oligosaccharide esters and xanthones. Considering the aforementioned findings, it was hypothesized that phenolic acids, phthalides, phenylethanoid glycosides, iridoid glycosides, and oligosaccharide esters could potentially serve as the pivotal active components contributing to the pharmacological effects of the JKZP. All components absorbed into the serum are shown in Table 4 (after the exclusion of duplicates and endogenous components).

TABLE 4

No.ComponentClassificationSourceNo.ComponentClassificationSource
1Ferulic acidPhenolic acidsChuanxiong, Shichangpu21CornusideIridoid glycosidesShanzhuyu
2Isochlorogenic acid APhenolic acidsChuanxiong22Cornusdiglycoside HIridoid glycosidesShanzhuyu
3LigustilidePhthalidesChuanxiong23LoganinIridoid glycosidesShanzhuyu
4Senkyunolide HPhthalidesChuanxiong24Loganic acidIridoid glycosidesShanzhuyu
5Senkyunolide IPhthalidesChuanxiong25Logmalicid AIridoid glycosidesShanzhuyu
6DanshensuPhenolic acidsDanshen26Logmalicid BIridoid glycosidesShanzhuyu
7Gallic acidPhenolic acidsDanshen27MorronisideIridoid glycosidesShanzhuyu
8Lithospermic acidPhenolic acidsDanshen28SwerosideIridoid glycosidesShanzhuyu
9Protocatechuic aldehydePhenolic acidsDanshen297-O-Galloyl-D-sedoheptulosePhenolic acidsShanzhuyu
10Rosmarinic acidPhenolic acidsDanshen307α-MorronisideIridoid glycosidesShanzhuyu
11Salvianolic acid APhenolic acidsDanshen31Polygalatenoside AOligosaccharide estersYuanzhi
12Salvianolic acid BPhenolic acidsDanshen32Glomeratose AOligosaccharide estersYuanzhi
13Salvianolic acid DPhenolic acidsDanshen33Sibiricose A1Oligosaccharide estersYuanzhi
14Salvianolic acid YPhenolic acidsDanshen34Sibiricose A3Oligosaccharide estersYuanzhi
15NeocryptotanshinoneDiterpene quinonesDanshen35Sibiricose A5Oligosaccharide estersYuanzhi
16Tanshinone IDiterpene quinonesDanshen363,6′-Disinapoyl sucroseOligosaccharide estersYuanzhi
17Cistanoside APhenylethanoid glycosidesRoucongrong37Polygalaxanthone IIIXanthoneYuanzhi
18EchinacosidePhenylethanoid glycosidesRoucongrong38Polygalaxanthone XIXanthoneYuanzhi
19AucubinIridoid glycosidesShanzhuyu, Roucongrong39Sibiricaxanthone AXanthoneYuanzhi
20CorninIridoid glycosidesShanzhuyu

All components absorbed into the serum with their classification and source.

5.2 Q-marker prediction based on component specificity

Chuanxiong Rhizoma is the dried rhizome of the L. sinense Chuanxiong plant, which belongs to the Umbelliferae family. A study conducted by Liu (2016) revealed that Chuanxiong Rhizoma had six primary pharmacologic compounds: ferulic acid, senkyunolide A/I/H, ligustilide, and levistilide A. Phthalides and phenolic acids were commonly considered to be the active components in Chuanxiong Rhizoma. Therefore, senkyunolide H and ferulic acid can be identified as the specific components of Chuanxiong Rhizoma (Liu J. et al., 2022).

Salvia miltiorrhiza is the dried root and rhizome of S. miltiorrhiza Bunge, which belongs to the Labiatae family. Lai et al.'s (2022) study showed that danshensu, salvianolic acid A/B, lithospermic acid, and rosmarinic acid were the main phenolic acid active components of S. miltiorrhiza. As for danshensu presenting with species-origin specificity, it was regarded as a unique component of S. miltiorrhiza (Li et al., 2018).

Cistanches Herba refers to the dehydrated succulent stem, with leaf scales, of C. deserticola Ma, which belongs to the Orobanchaceae family. Yang et al. (2023) identified cistanoside analogs, such as echinacoside, geniposide, cistanoside A, acteoside, and isoacteoside, as the primary active components of Cistanches Herba. Additionally, echinacoside was considered one of the distinctive constituents found exclusively in Cistanches Herba.

Corni Fructus refers to the desiccated ripe sarcocarp of C. officinalis Sieb. et Zucc., which belongs to the Cornaceae family. In a study conducted by Liu (2022), it was found that the primary active components of Corni Fructus were iridoid glycosides and phenolic acid chemicals, and these included gallic acid, 5-HMF, protocatechuic acid, morroniside, sweroside, loganin, and cornuside I; particularly, loganin and morroniside were the peculiar constituents in Corni Fructus (Li et al., 2017).

Radix Polygalae refers to the dehydrated root of the Polygala tenuifolia Willd. or Polygala sibirica L. plant, which belongs to the Polygalaceae family. The medical properties of this substance may be attributed to its various components, such as xanthones, saponins, oligosaccharide esters, and lipids. One specific component, known as 3,6′-disinapoyl sucrose, was particularly distinctive of Radix Polygalae (Wu et al., 2018).

5.3 Q-marker prediction based on the compound compatibility environment

In this prescription, JKZP comprised tortoise plastron, dragon bones, Radix Polygalae, Acorus Tatarinowii, Salviae Miltiorrhizae, Chuanxiong Rhizoma, Corni Fructus, and Cistanches Herba in the proportions of 6:6:3:3:5:4:5:4. According to the theory of TCM, tortoise plastron excelled at tonifying essence and blood, nourishing the yin (阴), submerging the yang (阳), tonifying the heart, tranquilizing the mind, and removing stagnant blood (as per “the Classic of Materia Medica”), thereby establishing its role as the sovereignty herb. Concurrently, Acorus Tatarinowii served to eliminate phlegm for resuscitation and to facilitate the movement of qi (气), promoting the alleviation of depression. Dragon bones contributed to tranquillization with a potent prescription, while Chuanxiong Rhizoma was utilized for activating blood circulation, eliminating blood stasis, and facilitating the movement of qi (气), thereby promoting relief from depression. The trio of herbs functioned as ministerial herbs. Then, Cistanches Herba benefited essence and blood and tonified kidney yang; Salviae Miltiorrhizae activated blood circulation and eliminated blood stasis; Radix Polygalae stabilized the mind and strengthened the intellect; Corni Fructus consolidated yin(阴) and replenished essence. They also served as assistant herbs. Subsequent to this, Chuanxiong Rhizoma, proficient in clearing the way and ascending toward the head and eyes, was employed to guide the medicines to the site of illness, functioning as a courier herb. Overall, the combination of these herbs aimed to tonify the kidneys, benefit the essence, dissipate phlegm, eliminate blood stasis, tranquilize the mind, and alleviate depression.

Chinese medicines are predominantly utilized in clinical practice through the form of prescriptions. Contemporary pharmacological research has demonstrated that varied combinations or dosages of herbs would result in variations in the effectiveness and underlying pharmacodynamic properties. Hence, it is imperative to anticipate the distinctive quality indicators pertaining to the neuroprotective properties of JKZP based on the TCM prescriptions principles. The research conducted by Liu M. et al. (2022) has demonstrated a significant increase in the levels of danshensu sodium, protocatechuic aldehyde, rosmarinic acid, salvianolic acid A/B, cryptotanshinone, tanshinone Ⅰ, and tanshinone ⅡA in the extract of Salviae Miltiorrhizae and Chuanxiong Rhizoma when the two were combined. The combination of Chuanxiong Rhizoma and Salviae Miltiorrhizae with Pueraria lobata (Willd.) Ohwi for treating cardiac and cerebral diseases resulted in the presence of soy sapogenins, genistein, 3′-methoxy soy sapogenins, formononetin, and cryptotanshinone in the bloodstream. These compounds were closely associated with the targets AKR1B1, CA2, CA1, and ALDH2 (Tang Y. et al., 2022). It was found that the combination of Corni Fructus and Rehmannia glutinosa (Gaertn.) resulted in a notable increase in the dissolution of loganin, a bioactive compound found in Corni Fructus (Zhou and Cong, 2018). Lv et al. (2016) conducted a comprehensive analysis of the chemical components of Radix Polygalae before and after pairing it with Acorus Tatarinowii. The study found that the levels of the eight chemical constituents, such as tenuifoliside, sibiricose A5, and 3,6′-disinapoyl sucrose, remained unchanged. However, the concentration of the volatile constituent cis-β-asarone significantly decreased (Zhang et al., 2015). The role and therapeutic effect of Chinese herbal prescriptions could be attributed to the synergy between the individual drugs and active compounds. It was observed that when the same single drugs were combined in a compound environment, they exhibited different pharmacological material bases and mechanisms of action, resulting in varied therapeutic effects.

5.4 Q-marker prediction based on the association between components and effectiveness

The properties of the components determined the pharmacological effects, constituting the core element of the Q-marker, and were pivotal for the quality control in prescriptions. Synthesizing the above theories and analytical results, JKZP exhibited neuroprotective effects potentially related to the key absorption into the serum from Chuanxiong Rhizoma, Salviae Miltiorrhizae, Cistanches Herba, Corni Fructus, and Radix Polygalae.

5.4.1 Chuanxiong Rhizoma

The compounds of Chuanxiong Rhizoma, as recorded in the “Chinese Materia Medica,” encompassed senkyunolide, ferulic acid, and caffeic acid. Upon oral ingestion, the medicines entered the body and exerted their therapeutic effects either directly as basic components or after undergoing a series of metabolic processes. In the study by Liu Z. et al. (2022), rats were orally administered senkyunolide H at a dosage of 10 mg kg−1. After 24 h, the plasma, urine, bile, and feces samples were collected for analysis. A total of 32 metabolites were detected, with the primary metabolic reactions involving oxidation, hydrogenation, methylation, acetylation, dehydroxylation, glucuronidation, esterification, and cysteine binding.

Studies have indicated that senkyunolide H exhibited neuroprotective effects in animals with ischemia–reperfusion injury or by safeguarding neuronal cells from injury induced by oxygen–glucose deprivation and reperfusion (OGD/R) via the cAMP-PI3K/AKT signaling pathway or the PI3K/AKT/NF-κB signaling pathway. Additionally, senkyunolide H decreased the release of inflammatory factors in the brain tissues of mice with middle cerebral artery occlusion and enhanced the ability of neurons to resist apoptosis, leading to a decrease in neurological impairment, volume of brain tissue damage due to the lack of blood supply, and mortality of neurons, thereby demonstrating notable neuroprotective effects (Zhang et al., 2019). It bolstered the ability of neurons to withstand oxidative stress by reducing the generation of reactive oxygen species, mitigating the loss of mitochondrial membrane potential, restricting the release of cytochrome C, and decreasing the levels of malondialdehyde. Simultaneously, it augmented antioxidant enzyme activities, such as superoxide dismutase, catalase, and glutathione peroxidase (Luo et al., 2019). It also attenuated neuroinflammation by blocking the Prx1/TLR4/NF-kB, ERK and NF-κB signaling pathways (Han et al., 2018; Tan et al., 2022). These combined mechanisms contribute to its neuroprotective effects. Thus, it was further anticipated that senkyunolide H might function as a quality indicator for JKZP.

5.4.2 Salviae Miltiorrhizae

The primary active substances of Salviae Miltiorrhizae are phenolic acids and diterpene quinones (Xu et al., 2018). Danshensu and tanshinone ⅡA serve as the quality control indicators for the antioxidant and anti-apoptotic properties of Salviae Miltiorrhizae aqueous extracts, respectively (Zhou et al., 2012). The study conducted by Lai et al. (2022) analyzed the levels of six phenolic acids in a digested extract of S. miltiorrhiza using an artificial gastric fluid. The investigated components were danshensu, lithospermic acid, and salvianolic acid A/B, whose bioaccessibility followed the following order, from the highest to lowest: the percentages of danshensu (50.19%), salvianolic acid B (33.44%), lithospermic acid (27.34%), salvianolic acid A (21.71%), and rosmarinic acid (12.31%), respectively. A higher bioaccessibility indicated that the components could be readily metabolized and assimilated by the stomach and intestines, enabling them to efficiently deliver their therapeutic effect. Evidence has suggested that phenolic acids are more readily digested and released by artificial gastric juice. The experimental findings of Hu (2015) proved that when rats were administered phenolic acids intravenously via the tail vein, the presence and peak concentration of danshensu in rat plasma were significantly higher than those of salvianolic acid B, and the mean residence time and half-life of danshensu were significantly longer.

Numerous studies have demonstrated the significant effectiveness of danshensu in various aspects, which include its ability to restrain oxidative stress (Wang et al., 2020a), decrease neuroinflammation (Han et al., 2019; Ye et al., 2020; Bai et al., 2023), prevent apoptosis (Guo et al., 2015; Fan et al., 2016), promote angiogenesis (Yin et al., 2017), ameliorate neurogenesis (Wei et al., 2018), improve the mitochondrial function (Xue et al., 2022), and alleviate the toxic effects of Aβ proteins on the brain (Zheng et al., 2023). These findings suggest its potential therapeutic applications in neurodegenerative disorders (such as Parkinson's disease and Alzheimer's disease), cerebral ischemia or ischemia/perfusion injury, and other diseases related to the nervous system. Consequently, danshensu could be anticipated as one of the indicators of quality for JKZP.

5.4.3 Cistanches Herba

Cistanches Herba has been identified with more than 150 compounds (Song et al., 2021), and the “Pharmacopoeia of the People's Republic of China” has recorded echinacoside as its key active ingredient. In the study by Yan (2018), a thorough analysis was conducted on the plasma, urine, and feces of rats that were given Cistanches Herba extracts orally. The study found a total of 82 characteristic compounds, with echinacoside being one of the main components.

Previous studies have indicated that echinacoside exerted a wide range of neuroprotective effects, such as anti-neuroinflammation (Zhang et al., 2017a; Gao et al., 2020; Lu et al., 2022; Yang et al., 2022), promotion of hippocampal neurogenesis (Lu et al., 2022), inhibition of glutamatergic excitotoxicity (Lu et al., 2016), reduction of oxidative stress (Zhao et al., 2016; Zheng et al., 2019), prevention of apoptosis (Zhu et al., 2013; Wei et al., 2019), enhancement of mitochondrial function (Ma et al., 2019), mitigation of β-amyloid neurotoxicity (Shiao et al., 2017), stimulation of autophagy (Chen et al., 2019), and suppression of endoplasmic reticulum stress (Zhang et al., 2017b). These effects have contributed to improving learning memory and cognitive disorders, as well as depressive behaviors. Consequently, echinacoside has extensive applications in neurological-related diseases.

5.4.4 Corni Fructus

Iridoid glycosides were the characteristic components of Corni Fructus, with 91 compounds of this class being isolated. The “Pharmacopoeia of the People's Republic of China” designated the total content of morroniside and loganin as a quality control index for Corni Fructus (Fan et al., 2020). A study conducted by Li (2007) examined the pharmacokinetic process of loganin in rats following the oral administration of a single dosage of loganin and Corni Fructus extract. Administering loganin (20 mg kg−1) and Corni Fructus extract (40 mg kg−1) orally to rats led to a notable elevation in their blood concentration. The blood concentration of loganin reached its highest level at 69 min, whereas that of the Corni Fructus extract peaked at 51 min. The compounds exhibited elimination half-lives of 93.6 min and 99.4 min, respectively.

Loganin exhibited anti-neuroinflammatory properties by boosting the polarization of M2 microglia, lowering the release of inflammation-related mediators, and playing a protective role in ischemic stroke mouse models (Huo et al., 2023). Loganin has also demonstrated effects such as anti-neuronal apoptosis (Kwon et al., 2011; Tseng et al., 2019), anti-oxidative stress (Kwon et al., 2011), improvement of mitochondrial function (Zhou et al., 2023), modulation of neurotransmitter release (Shi et al., 2019), reduction in neuronal damage, and alleviation of cognitive deficits in animal models. It shows potential for treating ischemic stroke and neurological illnesses.

5.4.5 Radix Polygalae

Modern pharmacological studies have indicated that extracts from Radix Polygalae attenuated neuronal cell damage and ameliorated cognitive impairments associated with learning and memory in various animal models of neurodegenerative disorders (Yuan et al., 2021). The compound 3,6′-disinapoyl sucrose was included in the “Pharmacopoeia of the People's Republic of China” as a quality control marker for Radix Polygalae. In the study by Xiong et al. (2023), rats were orally administered the Radix Polygalae extract at a dosage of 5 g kg−1. The UPLC-MS/MS approach was employed to ascertain the compounds present in the plasma. The findings indicated that the plasma blood concentration of 3,6′-disinapoyl sucrose peaked at 2 h, reaching a maximum concentration of 241.70 ± 15.18 ug·L−1.

The compound 3,6′-disinapoyl sucrose possesses the properties of anti-oxidative stress (Shi et al., 2015; Tang X. et al., 2022), counteracting glutamate excitotoxicity (Hu et al., 2014), enhancing neuroplasticity (Hu et al., 2010), and promoting neurogenesis (Wang et al., 2021). Therefore, it was frequently employed to treat conditions such as ischemic stroke, insomnia, amnesia, and depressive disorders.

5.5 Q-marker prediction based on component measurability

The composition of TCM prescriptions is intricate and diverse. Clarifying their key active components is crucial for elucidating the mechanism of their efficacy. Therefore, the Q-marker should be measurable. Studies by Qu et al. (2020) and Li et al. (2008) have detected danshensu in the plasma of rats gavaged with the Salviae Miltiorrhizae aqueous extract. The concentration of danshensu in the plasma ranged from 5 to 500 ng mL−1, demonstrating a linear relationship with its transformation. The study by Zhao et al. (2020) used the UHPLC-MS/MS technology to assess the pharmacokinetics and bioavailability of active components of Radix Polygalae in rat serum. The results have shown that the absolute bioavailability of sibiricose A5, A6, and 3,6′-disinapoyl sucrose was 3.25%, 2.95%, and 2.36%, respectively. The study by Yang et al. (2020) used the HPLC method to quantify the components of Cistanches Herba, such as echinacoside, cistanoside A, acteoside, and isoacteoside. This approach facilitated a comprehensive evaluation of the quality of the prepared slices. The study by Liu (2022) employed a traditional, reliable, and stable liquid-phase method to determine the quality of Corni Fructus, which included morroniside, sweroside, loganin, gallic acid, 5-HMF, protocatechuic acid, and cornuside I. The biological activity results indicated that these seven chemical ingredients could be used as Q-markers for evaluating the quality of Corni Fructus. Yalu et al.'s (2023) research identified the main components of Chuanxiong Rhizoma by liquid chromatography, encompassing senkyunolide H, chlorogenic acid, n-butylphenol, ligustrazine, ferulic acid, ligustilide, and others.

In conclusion, senkyunolide H, danshensu, echinacoside, loganic acid, and 3,6′-disinapoyl sucrose, with high proprietary and measurability, were predicted to be the key pharmacological bases for the neuroprotective effects of JKZP based on the “five principles” of Q-marker determination. The chemical structures of the Q-marker of JKZP are shown in Figure 4, the maps of peaks in the JKZP aqueous extract and JKZP-containing serum are revealed in Supplementary Figures S2, S3, and the mechanisms of neuroprotection are listed in Table 5.

FIGURE 4

TABLE 5

No.CompoundSourceDisease/ModelEffectMechanismReference
1Senkyunolide HChuanxiongIschemic stroke model in vivoUpregulating the level of cAMP, p-CREB, p-AKT, p-PDK1, and PKAActivating cAMP-PI3K/AKT signaling pathwayJiang et al. (2022)
2Senkyunolide HChuanxiongIschemic stroke model in vitro and in vivoAnti-inflammation and anti-apoptosisActivating the PI3K/Akt/NF-κB pathwayZhang et al. (2019)
3Senkyunolide HChuanxiongPC12 cells induced oxidative stress by 1-methyl-4-phenylpyridinium in vitroAnti-oxidative and anti-apoptosisInhibiting the NF-κB/JNK/MAPK pathwayLuo et al. (2019)
4Senkyunolide HChuanxiongIntracerebral hemorrhage model in vivoAnti-inflammationInhibiting the Prx1/TLR4/NF-κB pathwayHan et al. (2018)
5Senkyunolide HChuanxiongLipopolysaccharide-mediated neuroinflammation and oxidative stress in BV2 microglia cells in vitroAnti-oxidative and anti-inflammationInhibiting the ERK and NF-κB pathwaysTan et al. (2022)
6DanshensuDanshenParkinson's disease models in vitro and in vivoAnti-oxidativeActivating the PI3K/AKT/Nrf2 pathwayWang et al. (2020b)
7DanshensuDanshenBone marrow–derived macrophages activated by a Toll-like receptor 2 (TLR2) agonist Pam3CSK4Anti-inflammationInhibiting the NF-κB signaling pathwayYe et al. (2020)
8DanshensuDanshenAstrocytes and microglia with cerebral ischemia–reperfusion injury in vitro and in vivoanti-inflammationPolarizing astrocytes from A1 to A2 and microglia from M1 to M2Bai et al. (2023)
9DanshensuDanshenParkinson's disease models in vivo induced by 1-methyl-4-phenyl-1.2,3,6-tetrahydropyridine (MPTP)Anti-inflammationInhibiting Iba1-positive cells in the substantia nigra and reducing the levels of interleukin-1β and tumor necrosis factor-α in the striatumHan et al. (2019)
10DanshensuDanshenIschemic stroke model in vivoAnti-autophagy and anti-apoptosisActivating the mTOR pathwayFan et al. (2016)
11DanshensuDanshenIschemic stroke model in vivoAnti-apoptosisActivating the PI3K/Akt signal pathwayGuo et al. (2015)
12DanshensuDanshenMyocardial infarction in vivoAccelerating angiogenesisActivating SDF-1/CXCR4 axisYin et al. (2017)
13DanshensuDanshenFocal cerebral ischemia in mice in vivoEnhancing neurogenesisIncreasing the newly formed arteries and the diameter of collateral arteries, leading to enhanced local cerebral blood flow recovery after a strokeWei et al. (2018)
14DanshensuDanshenPlatelet activation by analyzing aggregation and adhesion in vitroPreventing mitochondrial dysfunction and inhibiting platelet activationActivating the SIRT1/ROS/mtDNA pathwayXue et al. (2022)
15DanshensuDanshenAβ(1–42) fibrillation and neuron-like SH-SY5Y cells in vitroAnti-neurotoxicityInhibiting Aβ(1–42) aggregation and associated proteinopathies through regulation of the apoptotic pathwayZheng et al. (2023)
16EchinacosideRoucongrongParkinson's disease models in vivo with 1-methyl-4-phenyl-1.2,3,6-tetrahydropyridine-induced damageAnti-inflammationInhibiting the p38 MAPK and NF-κB p52 signalsZhang et al. (2017a)
17EchinacosideRoucongrongParkinson's disease models in vivo with 1-methyl-4-phenyl-1.2,3,6-tetrahydropyridine-induced damageAnti-inflammationInhibiting the NLRP3/caspase-1/IL-1β signaling pathwayGao et al. (2020)
18EchinacosideRoucongrongParkinson's disease models in vivo and LPS-induced BV2 cells in vitroAnti-inflammationInhibiting the IL-6/JAK2/STAT3 pathwayYang et al. (2022)
19EchinacosideRoucongrongDepression mice and N9 microglial cells stimulated by LPSAnti-inflammation and improving hippocampal neurogenesisActivating CREB/BDNF and JAK1/STAT3 signaling pathwayLu et al. (2022)
20EchinacosideRoucongrong4-Aminopyridine-evoked glutamate release in rat cerebrocortical nerve terminalsReducing glutamate-induced toxicityReducing voltage-dependent Ca (2+) entry and subsequent suppression of protein kinase C activityLu et al. (2016)
21EchinacosideRoucongrongHypobaric hypoxia-induced memory impairment in C57 mice in vivoAnti-oxidativeActivating the Keap1/Nrf2/ARE signaling pathwayZheng et al. (2019)
22EchinacosideRoucongrongHypoxic–ischemic brain damage model in vivoAnti-oxidative and anti-apoptosisRecovering the antioxidant enzyme activities decreasing the caspase-3 levels and increasing the Bcl-2/Bax ratioWei et al. (2019)
23EchinacosideRoucongrongParkinson's disease model in vitro and in vivoAnti-apoptosisInhibiting the ROS/ATF3/CHOP pathwayZhao et al. (2016)
24EchinacosideRoucongrongNeuronal cells and non-neuronal cells with rotenone injury in vitroAnti-apoptosisActivating Trk receptors and their downstream signal pathwaysZhu et al. (2013)
25EchinacosideRoucongrongSH-SY5Y cells treated by an inhibitor of complexes I–IVImproving mitochondrial dysfunctionEnhancing complex II activity and mitochondrial respirationMa et al. (2019)
26EchinacosideRoucongrongAmyloid β peptide 1–42 [(Aβ(1–42)]–treated SH-SY5Y cells and an Aβ(1–42)-infused rat in vitro and in vivoAnti-neurotoxicityBlocking amyloid deposition via inhibiting amyloid oligomerization and reversing the cortical cholinergic neuronal function via decreasing amyloid neurotoxicityShiao et al. (2017)
27EchinacosideRoucongrongParkinson's disease model in vitro and in vivo with MPTP/MPP-induced neurotoxicityEnhancing autophagy in neuronsBinding to SIRT1 directly and affecting FoxO expressionChen et al. (2019)
28EchinacosideRoucongrongEndoplasmic reticulum stress model of rats and PC12 cells treated with 6-hydroxydopamine in vitro and in vivoAnti-endoplasmic reticulum stressInhibiting the Grp94/Bip/ATF4/CHOP pathwayZhang et al. (2017b)
29LoganinShanzhuyuIschemic stroke model in vivo and LPS-stimulated BV2 cells in vitroEnhancing autophagy and anti-inflammationRegulating α7nAChR-mediated microglial polarizationHuo et al. (2023)
30LoganinShanzhuyuSH-SY5Y cells–induced neuronal toxicity by H2O2Anti-apoptosisInhibiting JNK/p38 and ERK 1/2 MAPKsKwon et al. (2011)
31LoganinShanzhuyuPrimary mesencephalic neuronal cells treated with 1-methyl-4-phenylpyridinium in vitroAnti-apoptosisEnhancing neurotrophic signaling, activating IGF-1R/GLP-1R, and inhibiting the RhoA/ROCK pathwayTseng et al. (2019)
32LoganinShanzhuyuAlzheimer's disease models in vitro and in vivoPromoting mitophagy and mitochondrial functionActivating cell mitophagyZhou et al. (2023)
33LoganinShanzhuyuInsomnia models in vivoRegulating neurotransmitter releaseModification of the serotonergic system and GABAergic neuronsShi et al. (2019)
343,6′-Disinapoyl sucroseYuanzhiAβ(1–42)-induced neurotoxicity in Caenorhabditis elegansAnti-oxidativeRegulating expression of genes related to antioxidation and autophagyTang et al. (2022b)
353,6′-Disinapoyl sucroseYuanzhiSH-SY5Y cells induced by glutamate and H2O2in vitroReducing glutamate and H2O2-induced toxicityActivating the CaMKII and ERK1/2 pathwayHu et al. (2014)
363,6′-Disinapoyl sucroseYuanzhiChronic mild stress rats in vivoImproving levels of CAM-L1, laminin, and BDNFEnhancing hippocampal neuronal plasticityHu et al. (2010)
373,6′-Disinapoyl sucroseYuanzhiAlzheimer's disease model in vivoIncreasing hippocampal neurogenesisStrengthening neural stem cell proliferation and neuronal differentiationWang et al. (2021)

Q-markers of JKZP and its neuroprotective mechanisms.

6 Conclusion

JKZP exhibited the characteristics of tonifying the kidneys and marrow, promoting blood circulation, resolving stasis, and alleviating depression. Consequently, it has been utilized to address conditions such as stroke, post-stroke sequelae, vascular cognitive impairment, or dementia associated with kidney essence insufficiency, blood stasis obstruction, and blockage syndrome. It has had a notable impact on neuroprotection by inhibiting neuronal apoptosis, stimulating angiogenesis, and enhancing synaptic remodeling. Nevertheless, the lack of a distinct material foundation has severely hindered its progress and utilization. Hence, the article employed the UPLC-Q-TOF-MS/MS technology to examine and identify the compounds in the JKZP aqueous extract and JKZP-containing serum samples. This can serve as a source of information to further elucidate the pharmacological substance basis of JKZP.

The current study marked the first instance of analyzing and identifying the compounds of the aqueous extract of JKZP, along with the absorption into the serum. The aqueous extract contained a total of 12 chemical categories and 67 unique components identified. The JKZP-containing serum encompassed 111 components, comprising 33 prototype components and 78 metabolites. These components were derived from a pool of 39 original components. Iridoid glycosides, phenolic acids, oligosaccharide esters, phenylethanoid glycosides, and phthalides were posited as the potential key pharmacophore basis of JKZP. A comparison of the obtained compounds with the literature demonstrated the satisfactory results of this assay, with key compounds detected in all herbs except for dragon bones. The neuroprotective effects of JKZP were attributed to five specific components: senkyunolide H, danshensu, echinacoside, loganin, and 3,6-disinapoyl sucrose. These components have strong measurability and characterization and are believed to be the main pharmacological foundations for the neuroprotective effects of JKZP, according to the “five principles” of Q-marker determination. Prior studies have emphasized the function of the blood–brain barrier (BBB) in safeguarding the brain from exogenous, neurotoxic, and other substances in the blood, thereby impeding the passage of nearly 98% of small-molecule drugs. Therefore, the ability to traverse the BBB and target particular regions of the brain tissue is an essential property of chemicals or molecules that exhibit neuroprotective effects (Hornok et al., 2022; Katila et al., 2022). As previously stated, there is compelling evidence that all the aforementioned predicted Q-markers described could cross the BBB and provide varying degrees of neuroprotection (Li, 2007; Zhang et al., 2011; Wang et al., 2013; Zhu et al., 2013; Yang, 2019). Thus, they might be regarded as the Q-marker for JKZP.

Ultimately, this work primarily examined the properties of JKZP compounds and their uptake into the rat serum through the utilization of UPLC-Q-TOF-MS/MS technology. Senkyunolide H, danshensu, echinacoside, loganin, and 3,6′-disinapoyl sucrose have been predicted as Q-markers for JKZP. These findings provide empirical evidence to support the assessment of the quality and application of JKZP, serving as a reliable foundation for the theoretical advancement of prescriptions. However, certain constraints endured, Acorus Tatarinowii and Chuanxiong Rhizoma in this prescription contained more volatile oil components, which brought out the effects of opening the mind, awakening the brain, and alleviating depression. The study did not specifically prioritize the detection and identification of these volatile oil components nor did it reconfirm the neuroprotective benefits of Q-markers on neurodegenerative and ischemic stroke illnesses. Subsequent studies may concentrate on a comprehensive examination of volatile oil components and perform trials both in vivo and in vitro to validate the neuroprotective benefits of JKZP's Q-markers with the aim to further enhance the fundamental research on the pharmacodynamic substances of JKZP.

Statements

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material; further inquiries can be directed to the corresponding authors.

Author contributions

QW: Writing–original draft, Writing–review and editing. CO: Data curation, Writing–original draft. JW: Conceptualization, Data curation, Writing–review and editing. XW: Conceptualization, Data curation, Formal Analysis, Writing–review and editing. ZG: Data curation, Writing–review and editing. YZ: Conceptualization, Data curation, Writing–review and editing. GL: Conceptualization, Writing–review and editing. ZW: Conceptualization, Formal Analysis, Writing–review and editing. HY: Conceptualization, Data curation, Supervision, Writing–original draft, Writing–review and editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (81202641), the Natural Science Foundation of Shandong Province (ZR2020MH345), and Independent Innovation Team Project of Jinan (2020GXRC012).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2024.1328632/full#supplementary-material

References

Summary

Keywords

Jiawei Kongsheng Zhenzhong Pill, compounds, Chinese herbal prescription, ultra-performance liquid chromatography quadrupole time-of-flight mass tandem spectrometry, quality marker, neuroprotective effect, pharmacodynamic material basis

Citation

Wu Q, Ou C, Wang J, Wu X, Gao Z, Zhao Y, Lu G, Wu Z and Yu H (2024) Jiawei Kongsheng Zhenzhong Pill: marker compounds, absorption into the serum (rat), and Q-markers identified by UPLC-Q-TOF-MS/MS. Front. Pharmacol. 15:1328632. doi: 10.3389/fphar.2024.1328632

Received

27 October 2023

Accepted

11 January 2024

Published

05 February 2024

Volume

15 - 2024

Edited by

Dâmaris Silveira, University of Brasilia, Brazil

Reviewed by

Jia-Wen Shou, The Chinese University of Hong Kong, China

Fang Zhao, China Pharmaceutical University, China

Updates

Copyright

*Correspondence: Zhichun Wu, ; Huayun Yu,

†These authors have contributed equally to this work and share the first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics